Adagio Medical Holdings (ADGM) FCF Margin (2023 - 2024)

Adagio Medical Holdings (ADGM) reported FCF Margin of 5286.36% for Q3 2024, down 107.02% quarter-over-quarter from 2553.54% in Q2 2024.

Adagio Medical Holdings (ADGM) FCF Margin (2023 - 2024) Analysis & Trends

Adagio Medical Holdings (ADGM) has 2 years of FCF Margin data on file, last reported at 5286.36% in Q3 2024.

FCF Margin for Q3 2024 came in at 5286.36%, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was 8471.21% (changed N/A YoY), and the FY2024 annual result was 5482.9%, up 307010.0% from the prior year.
FCF Margin retreated to 5286.36% in Q3 2024 per ADGM's latest filing, from 2553.54% in the prior quarter.
Over five years, FCF Margin peaked at 2553.54% in Q2 2024 and troughed at 26392.31% in Q1 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Margin (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	8.20%
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	6.89%
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	25.51%
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	3.29%
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	-1.28%
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	6.68%
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	37.67%
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	3.98%
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	15.44%
10	Adagio Medical Holdings	15.88 Mn	2.97 Mn	-	-

Download Data